Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax’s CpG 1018 Adjuvant for Biological E’s COVID-19 Vaccine Candidate
- Tuesday, July 6, 2021, 7:04
- Finance
- Add a comment
EMERYVILLE, Calif. and HYDERABAD, India, July 6, 2021 /PRNewswire/ — Dynavax Technologies Corporation (Dynavax, Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines and Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical…
About the Author
adminasapcorp has written 41546 stories on this site.